Cell Therapy Bioprocessing Market is expected to reach US$ 30,052.61 million by 2028 With Fresenius Kabi AG, Asahi Kasei Corporation, Sartorius AG, Merck KGaA, Thermo Fisher Scientific Inc, Corning Incorporated, Cytiva (GE Healthcare), Lonza, Repligen, an

According to our new research study on “Cell Therapy Bioprocessing Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by technology, cell type, end user,” the market is expected to reach US$ 30,052.61 million in 2028 from US$ 11,192.50 million in 2020. The market is estimated to grow with a CAGR of 13.5% from 2021-2028. Genome editing (also known as genome editing) refers to a collection of technologies that enable scientists to alter an organism's DNA. These technologies allow for the addition, removal, or modification of genetic material at specific points in the genome. Several approaches to genome editing have been developed. CRISPR-Cas9 (clustered regularly interspaced short palindromic repeats)is the most common, cheap and efficient system used for genome editing. It is a short for clustered regularly interspaced short palindromic repeats and CRISPR-associated protein. Since it is quicker, easier, more precise, and effective than other genome editing approaches, the CRISPR-Cas9 system has fueled a lot of interest in the scientific community.

To get sample Copy of the report, along with the TOC, Statistics, and Tables please visit @ https://www.theinsightpartners.com/sample/TIPRE00021550/?openpr-10225

In the prevention and treatment of human diseases, genome editing is of vital significance. The majority of genome editing research is currently conducted using cells and animal models to better understand diseases. It's being researched for even a variety of diseases, including single-gene conditions such as cystic fibrosis, hemophilia, and sickle cell disease. Other genome editing technologies are Zinc-finger nuclease and TALENs stands for 'Transcription activator-like effector nucleases'. Therefore, increasing research on the utilization of gene technology is driving the growth of the market.

Based on technology, the cell therapy bioprocessing market is segmented into bioreactor, lyophilization, electro spinning, controlflow centrifugation, ultrasonic lysis, genome editing technology, cell immortalization technology, and viral vector technology. The Bioreactor segment held the largest share of the market in 2020, whereas the genome editing technology segment is anticipated to register the highest CAGR of 14.5% in the market during the forecast period.

The cell therapy bioprocessing market majorly consists of the players such as Fresenius Kabi AG, Asahi Kasei Corporation, Sartorius AG, Merck KGaA, Thermo Fisher Scientific Inc, Corning Incorporated, Cytiva (GE Healthcare), Lonza, Repligen, and Catalent Inc;. The companies are adopting inorganic and organic growth strategies to expand their global footprints and product portfolio. For instance, in January 2020, Asahi Kasei expands scope of license regarding allogenic iPS cell-derived cartilage. The amended agreement grants Asahi Kasei a worldwide licence for iPS cell-related patents licenced by iPS Academia Japan in the area of treating osteoarthritis and meniscus injury in addition to traumatic articular cartilage damage, non-exclusive for iPS cell-inducing technology, and exclusive for chondrification technology.

The report segments global cell therapy bioprocessing market as follows:

By Technology

Bioreactor
Lyophilization
Electrospinning
Controlflow Centrifugation
Ultrasonic Lysis
Genome Editing Technology
Cell Immortalization Technology
Viral Vector Technology

By Cell Type

Stem Cell
Immune Cell
Human Embryonic Stem Cell
Pluripotent Stem Cell
Hematopoetic Stem Cell

By Indication

Cardiovascular Disease (CVD)
Oncology
Wound Healing
Orthopedic
Others

By End User

Hospitals and Clinics
Diagnostic Centers
Regenerative Medicine Centers
Academic and Research Institute

By Geography

North America
US
Canada
Mexico
Europe
France
Germany
UK
Spain
Italy
Rest of Europe
Asia Pacific (APAC)
China
India
Japan
Australia
South Korea
Rest of APAC
Middle East and Africa (MEA)
Saudi Arabia
UAE
South Africa
Rest of MEA
South and Central America (SCAM)
Brazil
Argentina
Rest of SCAM

Interested in purchasing this Report? Click here @ https://www.theinsightpartners.com/buy/TIPRE00021550/?openpr-10225

Contact Us
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are committed to provide highest quality research and consulting services to our customers. We help our clients understand the key market trends, identify opportunities, and make informed decisions with our market research offerings at an affordable cost.
We understand syndicated reports may not meet precise research requirements of all our clients. We offer our clients multiple ways to customize research as per their specific needs and budget

This release was published on openPR.